On the use of corticosteroids for 2019-nCoV pneumonia

doi:10.1016/S0140-6736(20)30361-5

Comment

. 2020 Feb 29;395(10225):683-684.

doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.

On the use of corticosteroids for 2019-nCoV pneumonia

Lianhan Shang¹, Jianping Zhao², Yi Hu³, Ronghui Du⁴, Bin Cao⁵

Affiliations

¹ Beijing University of Chinese Medicine, Beijing, China; Department of Pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
² Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
³ Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Wuhan, China.
⁴ Department of Pulmonary and Critical Care Medicine, Wuhan Pulmonary Hospital, Wuhan, China.
⁵ Department of Pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China; Tsinghua University-Peking University Joint Center for Life Sciences, Beijing, China. Electronic address: caobin_ben@163.com.

PMID: 32122468
PMCID: PMC7159292
DOI: 10.1016/S0140-6736(20)30361-5

Comment

On the use of corticosteroids for 2019-nCoV pneumonia

Lianhan Shang et al. Lancet. 2020.

. 2020 Feb 29;395(10225):683-684.

doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.

Authors

Lianhan Shang¹, Jianping Zhao², Yi Hu³, Ronghui Du⁴, Bin Cao⁵

Affiliations

¹ Beijing University of Chinese Medicine, Beijing, China; Department of Pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
² Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
³ Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Wuhan, China.
⁴ Department of Pulmonary and Critical Care Medicine, Wuhan Pulmonary Hospital, Wuhan, China.
⁵ Department of Pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China; Tsinghua University-Peking University Joint Center for Life Sciences, Beijing, China. Electronic address: caobin_ben@163.com.

PMID: 32122468
PMCID: PMC7159292
DOI: 10.1016/S0140-6736(20)30361-5

No abstract available

PubMed Disclaimer

Figures

See this image and copyright information in PMC

Comment in

Contrasting evidence for corticosteroid treatment for coronavirus-induced cytokine storm.
Leung KKY, Hon KL, Qian SY, Cheng FWT. Leung KKY, et al. Hong Kong Med J. 2020 Jun;26(3):269-271. doi: 10.12809/hkmj208517. Epub 2020 Jun 5. Hong Kong Med J. 2020. PMID: 32536610 No abstract available.

Comment on

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.
Russell CD, Millar JE, Baillie JK. Russell CD, et al. Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7. Lancet. 2020. PMID: 32043983 Free PMC article. No abstract available.

Cited by

Different clinical presentations of two renal transplant recipients with coronavirus disease 2019: a case report.
Li J, Chen G, Zhang M, Tu S, Chen C. Li J, et al. BMC Infect Dis. 2020 Sep 25;20(1):707. doi: 10.1186/s12879-020-05434-4. BMC Infect Dis. 2020. PMID: 32977764 Free PMC article.
Clinical evidence of an interferon-glucocorticoid therapeutic synergy in COVID-19.
Lu Y, Liu F, Tong G, Qiu F, Song P, Wang X, Zou X, Wan D, Cui M, Xu Y, Zheng Z, Hong P. Lu Y, et al. Signal Transduct Target Ther. 2021 Mar 3;6(1):107. doi: 10.1038/s41392-021-00496-5. Signal Transduct Target Ther. 2021. PMID: 33658482 Free PMC article.
Steroids: A Therapeutic Option for COVID-19 Pneumonia Patients With ESRD?
Delafosse M, Saint-Jaques C, Petit-Hoang C, François H, Peltier J, Nicolet L, Verney C, Viguier M, Letavernier E, Dahan K. Delafosse M, et al. Kidney Int Rep. 2020 Jun 17;5(8):1375. doi: 10.1016/j.ekir.2020.05.031. eCollection 2020 Aug. Kidney Int Rep. 2020. PMID: 32775845 Free PMC article. No abstract available.
Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH).
Díaz E, Amézaga Menéndez R, Vidal Cortés P, Escapa MG, Suberviola B, Serrano Lázaro A, Marcos Neira P, Quintana Díaz M, Catalán González M. Díaz E, et al. Med Intensiva (Engl Ed). 2021 Mar;45(2):104-121. doi: 10.1016/j.medin.2020.06.017. Epub 2020 Jul 11. Med Intensiva (Engl Ed). 2021. PMID: 32854988 Free PMC article. Review.
COPD & COVID-19.
Halpin DMG, Vogelmeier CF, Agusti AA. Halpin DMG, et al. Arch Bronconeumol (Engl Ed). 2021 Mar;57(3):162-164. doi: 10.1016/j.arbr.2021.01.004. Epub 2021 Mar 10. Arch Bronconeumol (Engl Ed). 2021. PMID: 33994646 Free PMC article. No abstract available.

See all "Cited by" articles

References

1. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020 doi: 10.1016/S0140-6736(20)30317-2. published online Feb 7. - DOI - PMC - PubMed
1. WHO Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Jan 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-ac...
1. Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343. - PMC - PubMed
1. Chen RC, Tang XP, Tan SY, et al. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience. Chest. 2006;129:1441–1452. - PMC - PubMed
1. Li H, Yang SG, Gu L, et al. Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia. Influenza Other Respir Viruses. 2017;11:345–354. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information

[1] Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020 doi: 10.1016/S0140-6736(20)30317-2. published online Feb 7. - DOI - PMC - PubMed

[2] Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020 doi: 10.1016/S0140-6736(20)30317-2. published online Feb 7. - DOI - PMC - PubMed

[3] WHO Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Jan 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-ac...

[4] WHO Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Jan 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-ac...

[5] Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343. - PMC - PubMed

[6] Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343. - PMC - PubMed

[7] Chen RC, Tang XP, Tan SY, et al. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience. Chest. 2006;129:1441–1452. - PMC - PubMed

[8] Chen RC, Tang XP, Tan SY, et al. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience. Chest. 2006;129:1441–1452. - PMC - PubMed

[9] Li H, Yang SG, Gu L, et al. Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia. Influenza Other Respir Viruses. 2017;11:345–354. - PMC - PubMed

[10] Li H, Yang SG, Gu L, et al. Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia. Influenza Other Respir Viruses. 2017;11:345–354. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

On the use of corticosteroids for 2019-nCoV pneumonia

Affiliations

On the use of corticosteroids for 2019-nCoV pneumonia

Authors

Affiliations

Figures

Comment in

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical